INOVA FAIRFAX HOSPITAL — History
CCN 490063 | 3-year financial timeline | COVID resilience: 86/100
🛡️ Public data only — no PHI permitted on this instance.
$2.4B
Latest Revenue (FY2022)
+15.5%
Revenue CAGR (3yr)
20.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.8B | $2.2B | $2.4B | +11.8% | +15.5% |
| Operating Expenses | $1.8B | $2.1B | $1.9B | -10.2% | +2.2% |
| Operating Margin | -1.4% | 1.1% | 20.5% | +1806.5% | +0.0% |
| Net Income | $-25M | $23M | $495M | +2032.3% | +0.0% |
| Licensed Beds | 824 | 794 | 860 | +8.3% | +2.2% |
| Total Patient Days | 243,128 | 273,824 | 285,827 | +4.4% | +8.4% |
| Medicare Day % | 26% | 24% | 24% | -1.6% | -4.3% |
| Medicaid Day % | 15% | 14% | 12% | -16.2% | -12.6% |
COVID Impact & Recovery
Resilience Score: 86/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +33.4% ($1.8B → $2.4B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+15.5%
This Hospital
+7.6%
State Avg
Latest Margin
20.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $2.7B | 31.5% |
| FY2024 (proj) | $3.0B | 42.5% |
| FY2025 (proj) | $3.3B | 53.5% |